MX2013007611A - Metodos para criopreservar y encapsular celulas. - Google Patents

Metodos para criopreservar y encapsular celulas.

Info

Publication number
MX2013007611A
MX2013007611A MX2013007611A MX2013007611A MX2013007611A MX 2013007611 A MX2013007611 A MX 2013007611A MX 2013007611 A MX2013007611 A MX 2013007611A MX 2013007611 A MX2013007611 A MX 2013007611A MX 2013007611 A MX2013007611 A MX 2013007611A
Authority
MX
Mexico
Prior art keywords
methods
cryopreserving
cells
encapsulating cells
encapsulating
Prior art date
Application number
MX2013007611A
Other languages
English (en)
Inventor
Sascha Abramson
Original Assignee
Anthrogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthrogenesis Corp filed Critical Anthrogenesis Corp
Publication of MX2013007611A publication Critical patent/MX2013007611A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente se describen los métodos para criopreservar células que hayan sido suspendidas en alginato, así como los métodos para encapsular las células criopreservadas que hayan sido suspendidas en alginato. Además se proporcionan en la presente las composiciones celulares que contienen células que han sido procesadas de acuerdo con los métodos que se describen en la presente.
MX2013007611A 2010-12-30 2011-12-29 Metodos para criopreservar y encapsular celulas. MX2013007611A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428427P 2010-12-30 2010-12-30
PCT/US2011/067716 WO2012092420A2 (en) 2010-12-30 2011-12-29 Methods for cryopreserving and encapsulating cells

Publications (1)

Publication Number Publication Date
MX2013007611A true MX2013007611A (es) 2013-12-06

Family

ID=46380967

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007611A MX2013007611A (es) 2010-12-30 2011-12-29 Metodos para criopreservar y encapsular celulas.

Country Status (10)

Country Link
US (1) US20120171295A1 (es)
EP (1) EP2658556A4 (es)
JP (1) JP2014514245A (es)
KR (6) KR20220038548A (es)
CN (1) CN103648507A (es)
AR (1) AR084752A1 (es)
AU (1) AU2011352154A1 (es)
CA (1) CA2823540A1 (es)
MX (1) MX2013007611A (es)
WO (1) WO2012092420A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045148B2 (en) 2000-12-06 2006-05-16 Anthrogenesis Corporation Method of collecting placental stem cells
MX352687B (es) 2001-02-14 2017-12-04 Anthrogenesis Corp Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella.
PL1976977T3 (pl) 2005-12-29 2015-12-31 Anthrogenesis Corp Populacje komórek macierzystych łożyska
KR20220119515A (ko) 2007-09-28 2022-08-29 셀룰래리티 인코포레이티드 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
CN102176919A (zh) 2008-08-22 2011-09-07 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
WO2011002959A1 (en) 2009-07-02 2011-01-06 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
EP2556145B1 (en) 2010-04-07 2016-07-20 Anthrogenesis Corporation Angiogenesis using placental stem cells
JP2013523823A (ja) 2010-04-08 2013-06-17 アントフロゲネシス コーポレーション 胎盤幹細胞を用いるサルコイドーシスの治療
NZ605505A (en) 2010-07-13 2015-02-27 Anthrogenesis Corp Methods of generating natural killer cells
EP2658557A1 (en) 2010-12-31 2013-11-06 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
CN113559126A (zh) 2011-06-01 2021-10-29 人类起源公司 利用胎盘干细胞治疗疼痛
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
AU2014215458A1 (en) 2013-02-05 2015-08-13 Anthrogenesis Corporation Natural killer cells from placenta
KR101480987B1 (ko) 2013-05-08 2015-01-09 사회복지법인 삼성생명공익재단 간세포 동결 보존용 무혈청 용액 및 이를 이용한 간세포 동결 보존방법
AU2017201074A1 (en) * 2014-07-17 2017-03-16 The Trustees Of The University Of Pennsylvania Manufacturing of multi-dose injection ready dendritic cell vaccines, combination therapies for blocking HER2 and HER3, and estrogen receptor positive HER2 breast cancer therapy
WO2016063208A1 (en) * 2014-10-20 2016-04-28 Stempeutics Research Pvt. Ltd. A cryopreservation composition and methods thereof
ES2774456T3 (es) 2014-12-30 2020-07-21 Cell Cure Neurosciences Ltd Poblaciones de células del RPE y métodos de generación de las mismas
CN107206061A (zh) * 2015-05-22 2017-09-26 布莱恩·J·赫尔尼奇 多剂量注射用树突状细胞疫苗的制备,用于阻断her2和her3的联合治疗和雌激素受体阳性her2乳腺癌治疗
CN105746493A (zh) * 2016-03-29 2016-07-13 深圳爱生再生医学科技有限公司 微囊化免疫细胞冻存与复苏方法
CN107693844A (zh) * 2016-08-07 2018-02-16 李媚 一种组合物凝胶与应用
CN106177918A (zh) * 2016-09-30 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种间充质干细胞注射液及其制备方法和应用
CN106538512B (zh) * 2016-10-08 2019-07-30 北京汉氏联合干细胞研究院有限公司 一种保持冻存细胞活性的干细胞凝胶制剂及其应用
CN108030766B (zh) * 2017-12-20 2021-04-30 吉林国健生命工程科学技术有限公司 可长期保存的胎盘亚全能干细胞凝胶制剂及制备方法
BR112020013238A2 (pt) * 2017-12-29 2020-12-01 Cell Cure Neurosciences Ltd. composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana
BR112020013848A2 (pt) * 2018-01-08 2020-12-01 Iovance Biotherapeutics, Inc. métodos para expandir linfócitos infiltrantes de tumor e para tratar um indivíduo com câncer, população de linfócitos infiltrantes de tumor, e, método para avaliar fatores de transcrição
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
CN108990964B (zh) * 2018-08-09 2022-01-28 华东理工大学 细胞冻存液
CN109329269A (zh) * 2018-11-14 2019-02-15 深圳先进技术研究院 一种组织和细胞冻存液及其冻存方法
CN109287618A (zh) * 2018-11-14 2019-02-01 深圳先进技术研究院 一种细胞和组织冻存保护剂及其冻存方法
KR102148998B1 (ko) * 2018-11-29 2020-08-27 에이치엘비셀 주식회사 간세포 및 캡슐화한 간세포 구상체의 동결 보존을 위한 동결보존용 무혈청 용액 및 이를 이용한 동결보존법
WO2021071430A1 (en) * 2019-10-08 2021-04-15 Cellresearch Corporation Pte. Ltd. A mesenchymal stem cell storing or transport formulation and methods of making and using the same
KR102301268B1 (ko) * 2019-10-24 2021-09-10 국립낙동강생물자원관 알긴산염 및 dmso를 포함하는 사상형 남세균의 동결보존용 조성물 및 상기 조성물을 이용한 사상형 남세균의 동결보존 방법
CN112970740A (zh) * 2020-12-22 2021-06-18 山东华领奥源生物科技有限公司 一种用于保存胎盘亚全能干细胞的凝胶溶液及其应用
WO2023201258A2 (en) * 2022-04-12 2023-10-19 Avenge Bio, Inc. Encapsulated cells and methods of preserving thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US5071741A (en) * 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
CN1566333A (zh) * 2003-07-02 2005-01-19 中国人民解放军军事医学科学院基础医学研究所 一种冷冻保存细胞的方法
WO2006122147A2 (en) * 2005-05-10 2006-11-16 Rutgers, The State University Of New Jersey Alginate poly-l-lysine encapsulation as a technology for controlled differentiation of embryonic stem cells
EP1789435B1 (en) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University A method for production of mature natural killer cell
MX2009008559A (es) * 2007-02-12 2009-08-21 Anthrogenesis Corp Hepatocitos y condorcitos de celulas madre de la placenta adherentes, y poblaciones de celulas enriquecidas con celulas madre de la placenta cd34+, cd45-.
ES2588438T3 (es) * 2008-03-27 2016-11-02 Biolife Solutions, Inc. Materiales y métodos para la recogida hipotérmica de sangre entera
AU2009316541B2 (en) * 2008-11-19 2015-08-06 Celularity Inc. Amnion derived adherent cells
US20100311036A1 (en) * 2009-06-09 2010-12-09 University Of South Carolina Methods for Augmentation of Cell Cryopreservation

Also Published As

Publication number Publication date
EP2658556A2 (en) 2013-11-06
CN103648507A (zh) 2014-03-19
JP2014514245A (ja) 2014-06-19
CA2823540A1 (en) 2012-07-05
AU2011352154A1 (en) 2013-07-18
KR20210052587A (ko) 2021-05-10
KR20190031588A (ko) 2019-03-26
KR20220038548A (ko) 2022-03-28
EP2658556A4 (en) 2015-03-04
KR20230084328A (ko) 2023-06-12
WO2012092420A3 (en) 2014-03-13
AR084752A1 (es) 2013-06-05
KR20130132966A (ko) 2013-12-05
WO2012092420A2 (en) 2012-07-05
US20120171295A1 (en) 2012-07-05
KR20200042022A (ko) 2020-04-22

Similar Documents

Publication Publication Date Title
MX2013007611A (es) Metodos para criopreservar y encapsular celulas.
EP2456856A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING THE VITABILITY OF CRYOCONESERVED CELLS
IL239027B (en) Antifreeze material, antifreeze and antifreeze compositions, their uses and methods of antifreeze preservation
EP2556163A4 (en) GLYCANES WITH HIGH MANOQUE CONTENT
SG10201610915XA (en) Methods and compositions for natural killer cells
TW201231056A (en) Metal salt compositions
WO2012088358A3 (en) Single mpdu frame signaling
EP3697820A4 (en) PROCESSES AND COMPOSITIONS RELATING TO GENETICALLY MODIFIED REGULATORY T-LYMPHOCYTES
CA2866116C (en) Expansion of alloantigen-reactive regulatory t cells
MX2013012920A (es) Composiciones que comprenden particulas de hidrogel.
MY160389A (en) Higher loading zinc-containing films
MY161601A (en) Films and compositions comprising the same
IL229176B (en) Cryopreserved, thawed and reactivated t cell containing compositions, methods of producing same and use of same in immunotherapy”
SG190738A1 (en) Non-linear acene derivatives and their use as organic semiconductors
IN2012DN03404A (es)
PH12014500714A1 (en) Stable sns-595 compositions and methods of preparation
IL222343A0 (en) Compositions comprising allogeneic th1 cells and uses thereof
IL224813B (en) Preparations containing killer th1 cells and their uses
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
GB201020671D0 (en) Passive immunotherapy
EP3087193A4 (en) Compositions and methods for providing active telomerase to cells in vivo
ZA201603270B (en) Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses
WO2015108605A3 (en) Microbial production of branched medium chain alcohols, such as 4- methylpentanol
MX2013005699A (es) Composiciones de interferon-beta estables conservadas.
MX337070B (es) Método para preparar un conjugado klh-egfrviii.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal